do not combine dpp-4 inhibitors with glp-1 receptor agonists recommendation Role of in Clinical Practice The Role of GLP-1, DPP-4,
Description
D.WortweinG.et al (2015)

This complementary mechanism explains why cagrilintide plus semaglutide produces 50% more weight loss than either alone

doi: 10.3390/life12010029 12 YumukVTsigosCFriedMSchindlerKBusettoLMicicDet al
I dont recommend microdosing, Defnet says

Latorre R, Sternini C, De Giorgio R, Greenwood-VanMeerveld B

Dual glucagon-like peptide 1 (GLP-1)/glucagon receptor agonists specifically optimized for multidose formulations
00174-1/asset/4ff9bb50-3a8f-4946-a683-db1579705072/main.assets/gr1.jpg)